Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pear Therapeutics (PEARQ)
OTHER OTC:PEARQ
Holding PEARQ?
Track your performance easily
PEARQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.02
Previous Close$0.01
Volume1.70K
Average Volume (3M)N/A
Market Cap
$143.00
Enterprise Value-$21.73M
Total Cash (Recent Filing)$59.34M
Total Debt (Recent Filing)$37.61M
Price to Earnings (P/E)―
Beta18.91
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.54
Shares Outstanding142,739,169
10 Day Avg. Volume170
30 Day Avg. VolumeN/A
Standard Deviation16.31
R-Squared0.00065
Alpha2.53
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.71
Enterprise Value/Gross Profit-4.82
Enterprise Value/Ebitda0.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
37.54%
Insiders
2.96% Mutual Funds
<0.01% Other Institutional Investors
59.49% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PEARQ FAQ
What was Pear Therapeutics’s price range in the past 12 months?
Pear Therapeutics lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Pear Therapeutics’s market cap?
Currently, no data Available
When is Pear Therapeutics’s upcoming earnings report date?
Pear Therapeutics’s upcoming earnings report date is May 13, 2024 which is 197 days ago.
How were Pear Therapeutics’s earnings last quarter?
Currently, no data Available
Is Pear Therapeutics overvalued?
According to Wall Street analysts Pear Therapeutics’s price is currently Overvalued.
Does Pear Therapeutics pay dividends?
Pear Therapeutics does not currently pay dividends.
What is Pear Therapeutics’s EPS estimate?
Pear Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pear Therapeutics have?
Pear Therapeutics has 142,739,000 shares outstanding.
What happened to Pear Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pear Therapeutics?
Among the largest hedge funds holding Pear Therapeutics’s share is Perceptive Advisors LLC. It holds Pear Therapeutics’s shares valued at N/A.
---
Pear Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Pear Therapeutics
Thimble Point Acquisition Corp is a blank check company. it is formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business.
---
PEARQ Earnings Call
Q3 2022
0:00 / 0:00
---
PEARQ Stock 12 Month Forecast
Average Price Target
―---